Oxytocin in schizophrenia: Pathophysiology and implications for future treatment

Kah Kheng Goh, Chun Hsin Chen, Hsien Yuan Lane

研究成果: 雜誌貢獻回顧型文獻同行評審

摘要

Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal behavior, such as social function deficits or other behaviors that are disconnected from reality. Dysregulation of oxytocin may play a role in regulating the expression of schizophrenia. Given ox-ytocin’s role in social cognition and behavior, a variety of studies have examined the potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. In this review, we highlight the evidence for the role of endogenous oxytocin in schizophrenia, from animal models to human studies. We further discuss the potential of oxytocin as a therapeutic agent for schizophrenia and its implication in future treatment.
原文英語
文章編號2146
頁(從 - 到)1-26
頁數26
期刊International journal of molecular sciences
22
發行號4
DOIs
出版狀態已發佈 - 二月 2 2021

ASJC Scopus subject areas

  • 催化
  • 分子生物學
  • 光譜
  • 電腦科學應用
  • 物理與理論化學
  • 有機化學
  • 無機化學

指紋

深入研究「Oxytocin in schizophrenia: Pathophysiology and implications for future treatment」主題。共同形成了獨特的指紋。

引用此